메뉴 건너뛰기




Volumn 22, Issue 3, 2009, Pages 143-149

Monitoring kidney and renal cyst volumes applying MR approaches on a rapamycin treated mouse model of ADPKD

Author keywords

Cysts; Kidney; MRI; Pcy

Indexed keywords

PLACEBO; RAPAMYCIN;

EID: 67650494304     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-008-0158-7     Document Type: Article
Times cited : (19)

References (25)
  • 1
    • 2942534582 scopus 로고    scopus 로고
    • Polycystic kidney disease: New understanding in the pathogenesis
    • DOI 10.1016/j.biocel.2004.03.012, PII S1357272504001396
    • PD Wilson 2004 Polycystic kidney disease: new understanding in the pathogenesis Int J Biochem Cell Biol 36 10 1868 1873 (Pubitemid 38760015)
    • (2004) International Journal of Biochemistry and Cell Biology , vol.36 , Issue.10 , pp. 1868-1873
    • Wilson, P.D.1
  • 2
    • 0035083551 scopus 로고    scopus 로고
    • The genetics and physiology of polycystic kidney disease
    • JP Calvet JJ Grantham 2001 The genetics and physiology of polycystic kidney disease Semin Nephrol 21 2 107 123 (Pubitemid 32230544)
    • (2001) Seminars in Nephrology , vol.21 , Issue.2 , pp. 107-123
    • Calvet, J.P.1    Grantham, J.J.2
  • 3
    • 0027925829 scopus 로고
    • Autosomal dominant polycystic kidney disease
    • PA Gabow 1993 Autosomal dominant polycystic kidney disease New Engl J Med 329 5 332 342
    • (1993) New Engl J Med , vol.329 , Issue.5 , pp. 332-342
    • Gabow, P.A.1
  • 5
    • 33745621035 scopus 로고    scopus 로고
    • Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): Is there light at the end of the tunnel?
    • DOI 10.1093/ndt/gfl246
    • G Walz 2006 Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel? Nephrol Dial Transplant 21 7 1752 1757 (Pubitemid 43985695)
    • (2006) Nephrology Dialysis Transplantation , vol.21 , Issue.7 , pp. 1752-1757
    • Walz, G.1
  • 6
    • 0036931712 scopus 로고    scopus 로고
    • A defect in novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish
    • DOI 10.1242/dev.00173
    • S Liu W Lu T Obara S Kuida J Lehoczky K Dewar IA Drummond DR Beier 2002 A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish Development (Cambridge, England) 129 24 5839 5846 (Pubitemid 36054625)
    • (2002) Development , vol.129 , Issue.24 , pp. 5839-5846
    • Liu, S.1    Lu, W.2    Obara, T.3    Kuida, S.4    Lehoczky, J.5    Dewar, K.6    Drummond, I.A.7    Beier, D.R.8
  • 8
    • 0035171012 scopus 로고    scopus 로고
    • The pck rat: A new model that resembles human autosomal dominant polycystic kidney and liver disease
    • DOI 10.1046/j.1523-1755.2001.00473.x
    • DJ Lager Q Qian RJ Bengal M Ishibashi VE Torres 2001 The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease Kidney Int 59 1 126 136 (Pubitemid 32055221)
    • (2001) Kidney International , vol.59 , Issue.1 , pp. 126-136
    • Lager, D.J.1    Qian, Q.2    Bengal, R.J.3    Ishibashi, M.4    Torres, V.E.5
  • 9
    • 0022639053 scopus 로고
    • A new mouse model of genetically transmitted polycystic kidney disease
    • H Takahashi Y Ueyama T Hibino Y Kuwahara S Suzuki K Hioki N Tamaoki 1986 A new mouse model of genetically transmitted polycystic kidney disease J Urol 135 6 1280 1283 (Pubitemid 16095895)
    • (1986) Journal of Urology , vol.135 , Issue.6 , pp. 1280-1283
    • Takahashi, H.1    Ueyama, Y.2    Hibino, T.3
  • 10
    • 11144322215 scopus 로고    scopus 로고
    • Dietary potassium citrate does not harm the pcy mouse
    • JA Tanner GA Tanner 2005 Dietary potassium citrate does not harm the pcy mouse Exp Biol Med (Maywood, NJ) 230 1 57 60
    • (2005) Exp Biol Med (Maywood, NJ) , vol.230 , Issue.1 , pp. 57-60
    • Tanner, J.A.1    Tanner, G.A.2
  • 14
    • 33746373106 scopus 로고    scopus 로고
    • Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: Correlation with hypertension and renal function
    • YR Lee KB Lee 2006 Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function Nephron 103 4 c173 180
    • (2006) Nephron , vol.103 , Issue.4 , pp. 173-180
    • Lee, Y.R.1    Lee, K.B.2
  • 16
    • 33750135522 scopus 로고    scopus 로고
    • CRISP: Opening a new frontier in the diagnosis and treatment of PKD
    • JJ Grantham 2006 CRISP: opening a new frontier in the diagnosis and treatment of PKD Nephrol News Issues 20 9 29 30
    • (2006) Nephrol News Issues , vol.20 , Issue.9 , pp. 29-30
    • Grantham, J.J.1
  • 18
    • 40049105387 scopus 로고    scopus 로고
    • Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging
    • DOI 10.1038/sj.ki.5002771, PII 5002771
    • DP Wallace YP Hou ZL Huang E Nivens L Savinkova T Yamaguchi M Bilgen 2008 Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging Kidney International 73 6 778 781 (Pubitemid 351323259)
    • (2008) Kidney International , vol.73 , Issue.6 , pp. 778-781
    • Wallace, D.P.1    Hou, Y.-P.2    Huang, Z.L.3    Nivens, E.4    Savinkova, L.5    Yamaguchi, T.6    Bilgen, M.7
  • 21
    • 34548156931 scopus 로고    scopus 로고
    • Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis
    • DOI 10.1345/aph.1K295
    • AS Peak A Sheller 2007 Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis Ann Pharmacotherapy 41 9 1481 1485 (Pubitemid 47311368)
    • (2007) Annals of Pharmacotherapy , vol.41 , Issue.9 , pp. 1481-1485
    • Peak, A.S.1    Sheller, A.2
  • 22
    • 0142073812 scopus 로고    scopus 로고
    • Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist
    • DOI 10.1038/nm935
    • VH Gattone 2nd X Wang PC Harris VE Torres 2003 Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist Nat Med 9 10 1323 1326 (Pubitemid 37279858)
    • (2003) Nature Medicine , vol.9 , Issue.10 , pp. 1323-1326
    • Gattone II, V.H.1    Wang, X.2    Harris, P.C.3    Torres, V.E.4
  • 23
    • 0142249413 scopus 로고    scopus 로고
    • EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats
    • DOI 10.1046/j.1523-1755.2003.00256.x
    • VE Torres WE Sweeney Jr X Wang Q Qian PC Harris P Frost ED Avner 2003 EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats Kidney Int 64 5 1573 1579 (Pubitemid 37323685)
    • (2003) Kidney International , vol.64 , Issue.5 , pp. 1573-1579
    • Torres, V.E.1    Sweeney Jr., W.E.2    Wang, X.3    Qian, Q.4    Harris, P.C.5    Frost, P.6    Avner, E.D.7
  • 24
    • 16244414716 scopus 로고    scopus 로고
    • Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats
    • DOI 10.1111/j.1523-1755.2004.00952.x
    • VE Torres WE Sweeney Jr X Wang Q Qian PC Harris P Frost ED Avner 2004 Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats Kidney Int 66 5 1766 1773 (Pubitemid 41094300)
    • (2004) Kidney International , vol.66 , Issue.5 , pp. 1766-1773
    • Torres, V.E.1    Sweeney Jr., W.E.2    Wang, X.3    Qian, Q.4    Harris, P.C.5    Frost, P.6    Avner, E.D.7
  • 25
    • 1942486801 scopus 로고    scopus 로고
    • Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease
    • DOI 10.1038/nm1004
    • VE Torres X Wang Q Qian S Somlo PC Harris VH Gattone 2nd 2004 Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease Nat Med 10 4 363 364 (Pubitemid 38508512)
    • (2004) Nature Medicine , vol.10 , Issue.4 , pp. 363-364
    • Torres, V.E.1    Wang, X.2    Qian, Q.3    Somlo, S.4    Harris, P.C.5    Gattone II, V.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.